ATE439375T1 - Immunogene t-helfer epitope von menschlichen tumorantigenen und deren verwendung in immunotherapeutischen methoden - Google Patents

Immunogene t-helfer epitope von menschlichen tumorantigenen und deren verwendung in immunotherapeutischen methoden

Info

Publication number: ATE439375T1
Authority: AT; Austria
Prior art keywords: tumour; present; immunotherapeutic methods; relates; immunogenic
Prior art date: 2004-10-02

Application number

AT05778354T

Other languages

English (en)

Inventor

Hans-Georg Rammensee

Toni Weinschenk

Joern Dengjel

Original Assignee

Immatics Biotechnologies Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-02

Filing date

2005-09-09

Publication date

2009-08-15

2005-09-09 Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh

2009-08-15 Application granted granted Critical

2009-08-15 Publication of ATE439375T1 publication Critical patent/ATE439375T1/de

Links

206010028980 Neoplasm Diseases 0.000 title abstract 4
230000001024 immunotherapeutic effect Effects 0.000 title abstract 3
238000000034 method Methods 0.000 title abstract 3
239000000427 antigen Substances 0.000 title 1
102000036639 antigens Human genes 0.000 title 1
108091007433 antigens Proteins 0.000 title 1
230000002163 immunogen Effects 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 3
230000000259 anti-tumor effect Effects 0.000 abstract 2
230000028993 immune response Effects 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
229960005486 vaccine Drugs 0.000 abstract 2
208000008839 Kidney Neoplasms Diseases 0.000 abstract 1
206010038389 Renal cancer Diseases 0.000 abstract 1
239000008186 active pharmaceutical agent Substances 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
210000004027 cell Anatomy 0.000 abstract 1
210000002443 helper t lymphocyte Anatomy 0.000 abstract 1
238000009169 immunotherapy Methods 0.000 abstract 1
201000010982 kidney cancer Diseases 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
210000004881 tumor cell Anatomy 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Toxicology (AREA)
Zoology (AREA)
Pharmacology & Pharmacy (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT05778354T 2004-10-02 2005-09-09 Immunogene t-helfer epitope von menschlichen tumorantigenen und deren verwendung in immunotherapeutischen methoden ATE439375T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP04023546A EP1642905B1 (de)	2004-10-02	2004-10-02	Immunogene T-Helfer Epitope von menschlichen Tumorantigenen und deren Verwendung in immunotherapeutischen Methoden
PCT/EP2005/009719 WO2006037421A2 (en)	2004-10-02	2005-09-09	Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes

Publications (1)

Publication Number	Publication Date
ATE439375T1 true ATE439375T1 (de)	2009-08-15

Family

ID=34926825

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT04023546T ATE421533T1 (de)	2004-10-02	2004-10-02	Immunogene t-helfer epitope von menschlichen tumorantigenen und deren verwendung in immunotherapeutischen methoden
AT05778354T ATE439375T1 (de)	2004-10-02	2005-09-09	Immunogene t-helfer epitope von menschlichen tumorantigenen und deren verwendung in immunotherapeutischen methoden

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AT04023546T ATE421533T1 (de)	2004-10-02	2004-10-02	Immunogene t-helfer epitope von menschlichen tumorantigenen und deren verwendung in immunotherapeutischen methoden

Country Status (11)

Country	Link
US (1)	US8067529B2 (de)
EP (2)	EP1642905B1 (de)
JP (2)	JP2008514208A (de)
AT (2)	ATE421533T1 (de)
AU (1)	AU2005291660B2 (de)
CA (1)	CA2583065A1 (de)
DE (2)	DE602004019215D1 (de)
ES (2)	ES2319286T3 (de)
PL (2)	PL1642905T3 (de)
SI (2)	SI1642905T1 (de)
WO (1)	WO2006037421A2 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0609121D0 (en)	2006-05-09	2006-06-21	Univ Birmingham	Peptide Therapy
US20090004213A1 (en) *	2007-03-26	2009-01-01	Immatics Biotechnologies Gmbh	Combination therapy using active immunotherapy
NZ582823A (en)	2007-07-27	2012-04-27	Immatics Biotechnologies Gmbh	Composition of tumour-associated peptides and related anti-cancer vaccine
TW200932260A (en) *	2007-11-28	2009-08-01	Oncotherapy Science Inc	STAT3 epitope peptides
TW201000119A (en) *	2008-06-10	2010-01-01	Oncotherapy Science Inc	MYBL2 epitope peptides and vaccines containing the same
ES2536465T3 (es) *	2008-10-01	2015-05-25	Immatics Biotechnologies Gmbh	Composición de péptidos tumor-asociados y relacionados con la vacuna contra el cáncer para el tratamiento de glioblastoma (GBM) y otros cánceres
AU2016204712B2 (en) *	2008-10-01	2018-03-01	Immatics Biotechnologies Gmbh	Novel immunotherapy against several tumors including neuronal and brain tumors
EP2342220B1 (de) *	2008-10-06	2021-05-12	The University Of British Columbia	Verfahren und systeme zur vorhersage missgefalteter proteinepitope
US9023802B2 (en)	2009-12-14	2015-05-05	Immatics Biotechnologies Gmbh	HLA-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
GB201004575D0 (en)	2010-03-19	2010-05-05	Immatics Biotechnologies Gmbh	Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers
GB201009222D0 (en)	2010-06-02	2010-07-21	Immatics Biotechnologies Gmbh	Improved cancer therapy based on tumour associated antigens derived from cyclin D1
SG191154A1 (en)	2010-12-14	2013-07-31	Immatics Biotechnologies Gmbh	Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
EP2970496B1 (de)	2013-03-12	2018-07-18	Institute of Arthritis Research LLC	Immunologisch aktives polypeptid
ES2900004T3 (es)	2013-08-05	2022-03-15	Immatics Biotechnologies Gmbh	Nueva inmunoterapia contra diversos tumores como el cáncer de pulmón, incluido el carcinoma de pulmón amicrocítico (NSCLC)
US10344073B2 (en)	2014-01-09	2019-07-09	Hadasit Medical Research Services And Development Ltd.	Cell compositions and methods for cancer therapy
CN113403338B (zh) *	2014-03-28	2025-07-15	华盛顿大学商业中心	乳腺癌和卵巢癌疫苗
US10137181B2 (en) *	2014-04-01	2018-11-27	INSERM (Institut National de la Santé et de la Recherche Médicale)	Isolated donor MHC-derived peptide and uses thereof
WO2015150491A1 (en) *	2014-04-01	2015-10-08	INSERM (Institut National de la Santé et de la Recherche Médicale)	An isolated donor mhc-derived peptide and uses thereof
NL2014935B1 (en)	2015-06-08	2017-02-03	Applied Immune Tech Ltd	T cell receptor like antibodies having fine specificity.
HK1254866A1 (zh) *	2015-06-25	2019-07-26	Immatics Biotechnologies Gmbh	用於骨髓瘤和其他癌症免疫治疗的新型细胞表位和细胞表位组合物
PH12022551111A1 (en)	2015-10-05	2023-08-23	Immatics Biotechnologies Gmbh	Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
GB201520550D0 (en)	2015-11-23	2016-01-06	Immunocore Ltd & Adaptimmune Ltd	Peptides
GB201520568D0 (en)	2015-11-23	2016-01-06	Immunocore Ltd	Peptides
GB201607535D0 (en) *	2016-04-29	2016-06-15	Immunocore Ltd & Adaptimmune Ltd	Peptides
GB201521746D0 (en)	2015-12-10	2016-01-27	Immatics Biotechnologies Gmbh	Novel peptides and combination of peptides for use in immunotherapy against CLL and other cancers
JP7054397B2 (ja) *	2016-06-27	2022-04-13	ジュノーセラピューティクスインコーポレイテッド	Ｍｈｃ－ｅ拘束性エピトープ、結合分子ならびに関連する方法および使用
JP7458318B2 (ja)	2018-02-12	2024-03-29	ハダシットメディカルリサーチサービシーズアンドディベロップメントリミテッド	癌治療のためのｓｌａｍｆ６スプライスバリアントの調節
EP3894543A1 (de) *	2018-12-14	2021-10-20	INSERM (Institut National de la Santé et de la Recherche Médicale)	Isolierte humane mhc-abgeleitete peptide und verwendungen davon zur stimulierung und aktivierung der suppressiven funktion von cd8cd45rc + cd45rc low tregs
WO2020215010A1 (en) *	2019-04-17	2020-10-22	Codiak Biosciences, Inc.	Compositions of exosomes and aav
IL267614A (en)	2019-06-24	2019-09-26	Lotem Michal	Nucleic acids to modulate SLAMF6 isoforms
CA3212964A1 (en) *	2021-03-11	2022-09-15	Mnemo Therapeutics	Tumor neoantigenic peptides
WO2025069022A1 (en) *	2023-09-28	2025-04-03	Hadasit Medical Research Services And Development Ltd.	Immunomodulating peptides and uses thereof
US20250216401A1 (en) *	2024-01-03	2025-07-03	The Terasaki Innovation Center	Method of detecting human leukocyte antigens (hla)
WO2026073347A1 (en) *	2024-10-04	2026-04-09	Institut De Recherches Cliniques De Montréal	Antibodies against slam family member 6 and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH06507787A (ja) *	1991-05-16	1994-09-08	コールドスプリングハーバーラボラトリー	Ｄ−型サイクリン並びにそれに関連する使用方法
AUPM322393A0 (en)	1993-12-24	1994-01-27	Austin Research Institute, The	Mucin carbohydrate compounds and their use in immunotherapy
US5912167A (en) *	1995-06-06	1999-06-15	Wisconsin Alumni Research Foundation	Autocatalytic cleavage site and use thereof in a protein expression vector
US6805861B2 (en)	1996-01-17	2004-10-19	Imperial College Innovations Limited	Immunotherapy using cytotoxic T lymphocytes (CTL)
GB9823897D0 (en) *	1998-11-02	1998-12-30	Imp College Innovations Ltd	Immunotherapeutic methods and molecules
EP1434860A2 (de) *	2001-09-28	2004-07-07	Incyte Genomics, Inc.	Enzyme
US20030194704A1 (en) *	2002-04-03	2003-10-16	Penn Sharron Gaynor	Human genome-derived single exon nucleic acid probes useful for gene expression analysis two
DE10225144A1 (de) *	2002-05-29	2003-12-18	Immatics Biotechnologies Gmbh	An MHC-Moleküle bindende Tumor-assoziierte Peptide
EP1369482A1 (de) *	2002-06-07	2003-12-10	Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts	Zielgene für die Diagnose und Behandlung von Krebs
WO2006113671A2 (en)	2005-04-15	2006-10-26	Oncomethylome Sciences, S.A.	Methylation markers for diagnosis and treatment of cancers

2004
- 2004-10-02 EP EP04023546A patent/EP1642905B1/de not_active Expired - Lifetime
- 2004-10-02 PL PL04023546T patent/PL1642905T3/pl unknown
- 2004-10-02 ES ES04023546T patent/ES2319286T3/es not_active Expired - Lifetime
- 2004-10-02 SI SI200431004T patent/SI1642905T1/sl unknown
- 2004-10-02 DE DE602004019215T patent/DE602004019215D1/de not_active Expired - Lifetime
- 2004-10-02 AT AT04023546T patent/ATE421533T1/de active
2005
- 2005-09-09 PL PL05778354T patent/PL1794190T3/pl unknown
- 2005-09-09 JP JP2007533893A patent/JP2008514208A/ja active Pending
- 2005-09-09 WO PCT/EP2005/009719 patent/WO2006037421A2/en not_active Ceased
- 2005-09-09 CA CA002583065A patent/CA2583065A1/en not_active Abandoned
- 2005-09-09 EP EP05778354A patent/EP1794190B9/de not_active Expired - Lifetime
- 2005-09-09 ES ES05778354T patent/ES2328945T3/es not_active Expired - Lifetime
- 2005-09-09 DE DE602005015990T patent/DE602005015990D1/de not_active Expired - Lifetime
- 2005-09-09 US US11/664,627 patent/US8067529B2/en not_active Expired - Fee Related
- 2005-09-09 AT AT05778354T patent/ATE439375T1/de active
- 2005-09-09 AU AU2005291660A patent/AU2005291660B2/en not_active Ceased
- 2005-09-09 SI SI200530786T patent/SI1794190T1/sl unknown
2011
- 2011-04-21 JP JP2011094758A patent/JP2011200231A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
JP2008514208A (ja)	2008-05-08
JP2011200231A (ja)	2011-10-13
DE602005015990D1 (de)	2009-09-24
WO2006037421A3 (en)	2006-06-29
US8067529B2 (en)	2011-11-29
EP1794190A2 (de)	2007-06-13
CA2583065A1 (en)	2006-04-13
EP1794190B1 (de)	2009-08-12
ES2319286T3 (es)	2009-05-06
DE602004019215D1 (de)	2009-03-12
AU2005291660A1 (en)	2006-04-13
PL1794190T3 (pl)	2010-01-29
AU2005291660B2 (en)	2010-02-18
EP1642905B1 (de)	2009-01-21
ES2328945T3 (es)	2009-11-19
WO2006037421A2 (en)	2006-04-13
US20090317428A1 (en)	2009-12-24
PL1642905T3 (pl)	2009-04-30
EP1642905A1 (de)	2006-04-05
SI1642905T1 (sl)	2009-04-30
SI1794190T1 (sl)	2009-12-31
EP1794190B9 (de)	2010-05-19
ATE421533T1 (de)	2009-02-15

Legal Events

Date

Code

Title

Description

2010-02-15

UEP

Publication of translation of european patent specification

Ref document number: 1794190

Country of ref document: EP

Publication	Publication Date	Title
ATE421533T1 (de)	2009-02-15	Immunogene t-helfer epitope von menschlichen tumorantigenen und deren verwendung in immunotherapeutischen methoden
EA200800677A1 (ru)	2008-08-29	Опухолеассоциированные пептиды, беспорядочно связывающиеся с молекулами класса ii человеческого лейкоцитарного антигена (hla)
EA200800676A1 (ru)	2008-08-29	Опухолеассоциированные пептиды, связывающиеся с молекулами человеческого лейкоцитарного антигена (hla) i или ii класса, и относящаяся к ним противораковая вакцина
EA202091879A3 (ru)	2020-12-30	Новые пептиды и комбинации пептидов для применения в иммунотерапии рака легких, в том числе немелкоклеточного рака легких (нмрл) и других видов рака